List of insiders holdings for Cidara Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Mundipharma AG 10% Owner | 2019-09-13 16:35:41 | 4,781,408 0 | 4,781,408 | Form 13G |
| Stein Jeffrey President & CEO | 2024-03-20 18:46:39 | 2,193,693 373,611 | 2,567,304 | Form 4 |
| ROCKLAGE SCOTT M 5AM Co-Investors III L.P. 5AM VENTURES III L.P. DIEKMAN JOHN D Schwab Andrew J. Director 10% Owner | 2021-02-16 11:39:44 | 2,006,511 0 | 2,006,511 | Form 13G |
| Kjellson Nina S Director | 2015-04-22 14:45:54 | 0 1,356,813 | 1,356,813 | Form 4 |
| ELMS STEVE Director | 2015-04-22 19:39:03 | 0 1,054,610 | 1,054,610 | Form 4 |
| Aisling Capital II LP AISLING CAPITAL PARTNERS LP AISLING CAPITAL PARTNERS LLC SCHIFF ANDREW N Purcell Dennis J Seachaid Pharmaceuticals Inc. 10% Owner | 2019-02-11 16:06:54 | 1,027,843 0 | 1,027,843 | Form 13G |
| Sandison Taylor Chief Medical Officer | 2024-03-20 18:47:07 | 711,345 0 | 711,345 | Form 4 |
| Tari Leslie CHIEF SCIENTIFIC OFFICER | 2024-03-20 18:47:41 | 592,431 1484 | 593,915 | Form 4 |
| Ward Shane COO & CLO | 2024-03-20 18:48:49 | 568,770 0 | 568,770 | Form 4 |
| Shah Preetam CFO & CBO | 2024-03-20 18:48:19 | 553,460 0 | 553,460 | Form 4 |
| Heron Patrick J Director | 2015-04-22 14:49:35 | 0 291,023 | 291,023 | Form 4 |
| Levine James E. Chief Financial Officer | 2021-03-19 21:12:52 | 199,803 50,000 | 249,803 | Form 4 |
| Daruwala Paul Chief Operating Officer | 2022-09-13 18:40:52 | 221,099 0 | 221,099 | Form 4 |
| Judice Kevin Director | 2015-04-14 19:48:33 | 186,553 0 | 186,553 | Form 3 |
| Forrest Kevin Chief Scientific Officer | 2017-04-04 16:40:56 | 132,354 0 | 132,354 | Form 4 |
| Thye Dirk Chief Medical Officer | 2016-03-18 16:05:44 | 80,000 0 | 80,000 | Form 4 |
| Johnson Brady Vice President, Finance | 2022-04-04 17:23:57 | 79,366 0 | 79,366 | Form 4 |
| Onaitis Matthew Gnrl Counsel, CFO & Secretary | 2018-04-02 17:18:55 | 72,000 0 | 72,000 | Form 4 |
| Abdollahian Neil Chief Business Officer | 2021-04-05 18:24:31 | 57,471 0 | 57,471 | Form 4 |
| Bartizal Ken Chief Development Officer | 2017-04-04 16:46:46 | 50,000 0 | 50,000 | Form 4 |
| Gollaher David L Director | 2023-06-23 17:15:46 | 42,500 0 | 42,500 | Form 4 |
| Bassler Bonnie L Director | 2023-06-23 17:17:41 | 42,500 0 | 42,500 | Form 4 |
| BURGESS DANIEL D Director | 2023-06-23 17:19:51 | 42,500 0 | 42,500 | Form 4 |
| Franson Timothy R Director | 2023-06-23 17:21:26 | 42,500 0 | 42,500 | Form 4 |
| Schroeder Theodore R Director | 2023-06-23 17:23:23 | 42,500 0 | 42,500 | Form 4 |
| Canale-Theakston Carin Director | 2023-06-23 17:31:20 | 42,500 0 | 42,500 | Form 4 |
| Mineo Chrysa Director | 2023-06-23 17:33:53 | 42,500 0 | 42,500 | Form 4 |
| Wilson Marc Chief Accounting Officer | 2017-09-19 16:44:14 | 20,356 0 | 20,356 | Form 4 |
| PEREZ ROBERT J Director | 2017-06-26 17:10:08 | 11,000 0 | 11,000 | Form 4 |
| ROCKLAGE SCOTT M Director | 2018-06-15 21:44:12 | 11,000 0 | 11,000 | Form 4 |
| Oien Jessica General Counsel & Secretary | 2021-04-05 17:35:45 | 7764 0 | 7764 | Form 4 |
| BIOTECH TARGET N V BB BIOTECH AG 10% Owner | 2022-02-11 16:48:00 | 0 0 | 0 | Form 13G |